James G. Hakim

Emergency Medicine

225 Williamson St
Elizabeth, NJ 07202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 116 publications

Impact of sub-optimal HIV viral control on activated T cells.

Impact of sub-optimal HIV viral control on activated T cells.

Journal: AIDS (London, England)

Published: February 01, 2023

Task-sharing with lay counsellors to deliver a stepped care intervention to improve depression, antiretroviral therapy adherence and viral suppression in people living with HIV: a study protocol for the TENDAI randomised controlled trial.

Task-sharing with lay counsellors to deliver a stepped care intervention to improve depression, antiretroviral therapy adherence and viral suppression in people living with HIV: a study protocol for the TENDAI randomised controlled trial.

Journal: BMJ open

Published: December 28, 2022

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.

Journal: The New England journal of medicine

Published: July 21, 2021

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.

Journal: The New England journal of medicine

Published: May 05, 2021

Prevalence and risk of residual viremia after ART in low- and middle-income countries: A cross-sectional study.

Prevalence and risk of residual viremia after ART in low- and middle-income countries: A cross-sectional study.

Journal: Medicine

Published: April 09, 2021

New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.

New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: December 11, 2020

Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.

Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.

Journal: AIDS (London, England)

Published: December 11, 2020

Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.

Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.

Journal: PloS one

Published: July 04, 2020

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.

Journal: The Journal of antimicrobial chemotherapy

Published: July 01, 2020

Clinically relevant enantiomer specific R- and S-praziquantel pharmacokinetic drug-drug interactions with efavirenz and ritonavir.

Clinically relevant enantiomer specific R- and S-praziquantel pharmacokinetic drug-drug interactions with efavirenz and ritonavir.

Journal: Pharmacology research & perspectives

Published: June 09, 2020

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Epidemic in Zimbabwe: Quo Vadis?

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Epidemic in Zimbabwe: Quo Vadis?

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 03, 2020

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.

Journal: BMC infectious diseases

Published: April 07, 2020

Showing 1-12 of 116

Last Updated: 09/26/2026